917 related articles for article (PubMed ID: 25703934)
1. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway.
Ito M; Kanno S; Nosho K; Sukawa Y; Mitsuhashi K; Kurihara H; Igarashi H; Takahashi T; Tachibana M; Takahashi H; Yoshii S; Takenouchi T; Hasegawa T; Okita K; Hirata K; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
Int J Cancer; 2015 Sep; 137(6):1258-68. PubMed ID: 25703934
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.
Ito M; Mitsuhashi K; Igarashi H; Nosho K; Naito T; Yoshii S; Takahashi H; Fujita M; Sukawa Y; Yamamoto E; Takahashi T; Adachi Y; Nojima M; Sasaki Y; Tokino T; Baba Y; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
Int J Cancer; 2014 Dec; 135(11):2507-15. PubMed ID: 24752710
[TBL] [Abstract][Full Text] [Related]
3.
Hussan H; Clinton SK; Roberts K; Bailey MT
World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
[TBL] [Abstract][Full Text] [Related]
4. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
5. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH; Bae JM; Cho NY; Kang GH
Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
[TBL] [Abstract][Full Text] [Related]
6. NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
Kim JH; Hong JH; Choi YL; Lee JA; Seo MK; Lee MS; An SB; Sung MJ; Cho NY; Kim SS; Shin YK; Kim S; Kang GH
J Pathol; 2021 Dec; 255(4):399-411. PubMed ID: 34402529
[TBL] [Abstract][Full Text] [Related]
7. Invasive Fusobacterium nucleatum may play a role in the carcinogenesis of proximal colon cancer through the serrated neoplasia pathway.
Yu J; Chen Y; Fu X; Zhou X; Peng Y; Shi L; Chen T; Wu Y
Int J Cancer; 2016 Sep; 139(6):1318-26. PubMed ID: 27130618
[TBL] [Abstract][Full Text] [Related]
8. CpG Island Methylator Phenotype-High Colorectal Cancers and Their Prognostic Implications and Relationships with the Serrated Neoplasia Pathway.
Rhee YY; Kim KJ; Kang GH
Gut Liver; 2017 Jan; 11(1):38-46. PubMed ID: 27885175
[TBL] [Abstract][Full Text] [Related]
9. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.
Kambara T; Simms LA; Whitehall VL; Spring KJ; Wynter CV; Walsh MD; Barker MA; Arnold S; McGivern A; Matsubara N; Tanaka N; Higuchi T; Young J; Jass JR; Leggett BA
Gut; 2004 Aug; 53(8):1137-44. PubMed ID: 15247181
[TBL] [Abstract][Full Text] [Related]
10. A novel pit pattern identifies the precursor of colorectal cancer derived from sessile serrated adenoma.
Kimura T; Yamamoto E; Yamano HO; Suzuki H; Kamimae S; Nojima M; Sawada T; Ashida M; Yoshikawa K; Takagi R; Kato R; Harada T; Suzuki R; Maruyama R; Kai M; Imai K; Shinomura Y; Sugai T; Toyota M
Am J Gastroenterol; 2012 Mar; 107(3):460-9. PubMed ID: 22233696
[TBL] [Abstract][Full Text] [Related]
11. IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions.
Naito T; Nosho K; Ito M; Igarashi H; Mitsuhashi K; Yoshii S; Aoki H; Nomura M; Sukawa Y; Yamamoto E; Adachi Y; Takahashi H; Hosokawa M; Fujita M; Takenouchi T; Maruyama R; Suzuki H; Baba Y; Imai K; Yamamoto H; Ogino S; Shinomura Y
World J Gastroenterol; 2014 Aug; 20(29):10050-61. PubMed ID: 25110432
[TBL] [Abstract][Full Text] [Related]
12. The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
Renaud F; Mariette C; Vincent A; Wacrenier A; Maunoury V; Leclerc J; Coppin L; Crépin M; Van Seuningen I; Leteurtre E; Buisine MP
Int J Cancer; 2016 Mar; 138(6):1472-81. PubMed ID: 26476272
[TBL] [Abstract][Full Text] [Related]
13. Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps.
Kim YH; Kakar S; Cun L; Deng G; Kim YS
Int J Cancer; 2008 Dec; 123(11):2587-93. PubMed ID: 18798261
[TBL] [Abstract][Full Text] [Related]
14. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.
Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S
JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352
[TBL] [Abstract][Full Text] [Related]
15. Subtypes of the Type II Pit Pattern Reflect Distinct Molecular Subclasses in the Serrated Neoplastic Pathway.
Aoki H; Yamamoto E; Yamano HO; Sugai T; Kimura T; Tanaka Y; Matsushita HO; Yoshikawa K; Takagi R; Harada E; Nakaoka M; Yoshida Y; Harada T; Sudo G; Eizuka M; Yorozu A; Kitajima H; Niinuma T; Kai M; Nojima M; Suzuki H; Nakase H
Dig Dis Sci; 2018 Jul; 63(7):1920-1928. PubMed ID: 29546645
[TBL] [Abstract][Full Text] [Related]
16. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
Lee DW; Han SW; Kang JK; Bae JM; Kim HP; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
Ann Surg Oncol; 2018 Oct; 25(11):3389-3395. PubMed ID: 30062471
[TBL] [Abstract][Full Text] [Related]
17. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.
Mima K; Nishihara R; Qian ZR; Cao Y; Sukawa Y; Nowak JA; Yang J; Dou R; Masugi Y; Song M; Kostic AD; Giannakis M; Bullman S; Milner DA; Baba H; Giovannucci EL; Garraway LA; Freeman GJ; Dranoff G; Garrett WS; Huttenhower C; Meyerson M; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S
Gut; 2016 Dec; 65(12):1973-1980. PubMed ID: 26311717
[TBL] [Abstract][Full Text] [Related]
18. Assessment of epigenetic alterations in early colorectal lesions containing BRAF mutations.
Sawada T; Yamamoto E; Yamano HO; Nojima M; Harada T; Maruyama R; Ashida M; Aoki H; Matsushita HO; Yoshikawa K; Harada E; Tanaka Y; Wakita S; Niinuma T; Kai M; Eizuka M; Sugai T; Suzuki H
Oncotarget; 2016 Jun; 7(23):35106-18. PubMed ID: 27145369
[TBL] [Abstract][Full Text] [Related]
19. Relationship between
Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and molecular characteristics of serrated lesions in Japanese elderly patients.
Nosho K; Igarashi H; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yoshii S; Mikami M; Takahashi H; Kusumi T; Hosokawa M; Sukawa Y; Adachi Y; Hasegawa T; Okita K; Hirata K; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
Digestion; 2015; 91(1):57-63. PubMed ID: 25632919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]